right now the problem is that the company just did a financing at $17 and it will take a while to digest that. i thought that was ill-advised, but since the stock is trading below $17, it looks good from management's point of view. once pirquitas starts producing, that should remove a great deal of risk from the stock, and if they successfully ramp up production in the second quarter, that would remove the last obstacle to re-rating the stock upward. at $20 silver, the net present value of pirquitas alone would be far more than the current market cap.